Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States

  • Chadi Nabhan1Email author,
  • Anthony Mato2,
  • Christopher R. Flowers3,
  • David L. Grinblatt4,
  • Nicole Lamanna5,
  • Mark A. Weiss6,
  • Matthew S. Davids7,
  • Arlene S. Swern8,
  • Shriya Bhushan8,
  • Kristen Sullivan9,
  • E. Dawn Flick10,
  • Pavel Kiselev8 and
  • Jeff P. Sharman11
BMC Cancer201717:198

https://doi.org/10.1186/s12885-017-3176-x

Received: 28 September 2016

Accepted: 8 March 2017

Published: 16 March 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
28 Sep 2016 Submitted Original manuscript
3 Oct 2016 Author responded Author comments - Chadi Nabhan
Resubmission - Version 2
3 Oct 2016 Submitted Manuscript version 2
16 Dec 2016 Reviewed Reviewer Report - Tamila Kindwall-Keller
26 Dec 2016 Reviewed Reviewer Report - Mario Tiribelli
12 Jan 2017 Author responded Author comments - Chadi Nabhan
Resubmission - Version 3
12 Jan 2017 Submitted Manuscript version 3
15 Feb 2017 Author responded Author comments - Chadi Nabhan
Resubmission - Version 4
15 Feb 2017 Submitted Manuscript version 4
22 Feb 2017 Author responded Author comments - Chadi Nabhan
Resubmission - Version 5
22 Feb 2017 Submitted Manuscript version 5
Publishing
8 Mar 2017 Editorially accepted
16 Mar 2017 Article published 10.1186/s12885-017-3176-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Cardinal Health Specialty Solutions
(2)
Center for CLL, Abramson Cancer Center, University of Pennsylvania
(3)
Emory University
(4)
NorthShore University HealthSystem
(5)
Leukemia Service, Hematologic Malignancies Section, Division of Hematology/Oncology, New York-Presbyterian Hospital/Columbia University Medical Center
(6)
Thomas Jefferson University
(7)
Dana-Farber Cancer Institute
(8)
Celgene Corporation
(9)
Celgene Corporation
(10)
Celgene Corporation
(11)
Willamette Valley Cancer Institute and Research Center

Advertisement